Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 769

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 769
---
 by reference or deemed to
be incorporated by reference in such registration statement.

“” has the meaning set
forth in Section 2.1(a).

“” means the Holders holding a majority of the Registrable Securities
outstanding from time to time.

“” means Rule 144 as promulgated by the SEC under the Securities Act, as such
rule may be amended from time to time, or any similar successor rule that may be promulgated by the SEC having substantially the same effect as such Rule.

“” means the Securities and Exchange Commission or any other federal agency at the time administering the Securities Act.

“” means any publicly-available written or oral guidance, comments, requirements or requests of the SEC
staff under the Securities Act; , that any such oral guidance, comments, requirements or requests are reduced to writing by the SEC.

“” means the Shares and Warrant Shares issued pursuant to the Subscription Agreement.

“” means the Securities Act of 1933, as amended, or any similar successor federal statute and the
rules and regulations thereunder, all as the same shall be in effect from time to time.

“” means the shares
of Common Stock issued or issuable to the Purchasers pursuant to the Subscription Agreement.

“” has the meaning set forth in Section 2.1(a).

“” means this Agreement, the
Subscription Agreement and the Pre-Funded Warrants, all exhibits and schedules thereto and hereto and any other documents or agreement executed in connection with the transactions contemplated hereunder or
thereunder.

“” means the shares of Common Stock issued or issuable upon the exercise of Pre-Funded Warrants.

E-3

2. .

2.1 .

(a) . On or prior to the later of (i) thirty (30) days following the Closing Date and (ii) five (5)
Business Days following the filing of the Company’s audited financial statements for the year ended December 31, 2024 (the “”), the Company shall prepare and file with the SEC a Registration Statement on
Form S-3 (or, if Form S-3 is not then available to the Company, on such form of registration statement as is then available to effect a registration for resale of the
Registrable Securities), subject to the provisions of , for the resale of the Registrable Securities pursuant to an offering to be made on a continuous basis pursuant to Rule 415 under the Securities Act (the
“”). Such Shelf Registration Statement shall, subject to the